Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride may be linked to Peyronie’s disease, but more research is needed.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

Minoxidil is strongly linked to heart problems, and machine learning can improve drug safety checks.

Certain medications, especially 5-alpha reductase inhibitors, are commonly linked to erectile dysfunction.

Finasteride and testosterone are the drugs most linked to male infertility, but many other potential drugs may be under-reported.

Chinchillas have specific blood and protein levels, with variations possibly linked to pregnancy or hair growth.

Some medications might contribute to male infertility, with finasteride showing a high number of reports.

Reporter characteristics affect detection of hair loss from cancer therapy.

The document concludes that better biomarkers are needed to detect long-term oral testosterone use in athletes.

Inhaled steroids in children may cause excessive hair growth and not always go away after stopping the medication.

Many patients with Alopecia Areata in Korea experience anxiety, depression, and reduced quality of life, which are often unrelated to the severity of hair loss.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Topical minoxidil effectively and safely treats female pattern hair loss, but other treatments need more research.

Acupuncture reduces anxiety and depression in women with PCOS.

Certain cancer drugs are strongly linked to nerve damage, requiring close monitoring and early treatment.

Many survivors of critical illness, especially those with sepsis, experience hair loss.

Digoxin is linked to a higher risk of anemia in patients with atrial fibrillation and heart failure.

Oral minoxidil may have more cardiovascular risks than topical minoxidil.

Finasteride can cause long-term side effects like sexual dysfunction and depression.

Ultrasound measurement of the ovarian stroma to total area ratio is not a reliable single predictor of high male hormone levels in Thai women with PCOS, but works better when combined with clinical signs.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Cladribine has known risks and potential new safety concerns, requiring careful monitoring.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

Statins may be linked to reproductive organ conditions, and their risks should be monitored.

EGFR-TKIs can cause significant skin, nail, and organ side effects.

Pexidartinib often causes liver issues and fatigue, especially in women.

New mutations in the SLC39A4 gene found in twins help understand the genetic cause of acrodermatitis enteropathica.

Rimegepant causes more nausea and skin issues, while ubrogepant causes more muscle issues; personalized treatment is important.

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

Mild essential fatty acid deficiency can cause health issues and is worsened by low-fat diets.